SCHEMBL5148079

SCHEMBL5148079

Clc1cccc(Nc2ccc3cc[nH]c3c2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.58
CMA1 P23946 1/20 0.58
ESR1 P03372 1/20 0.50
TTBK1 Q5TCY1 1/20 0.47
TTBK2 Q6IQ55 1/20 0.47
PYGL P06737 1/20 0.46
SYK P43405 1/20 0.45
GRM5 P41594 1/20 0.45
F7 P08709 1/20 0.44
LTA4H P09960 1/20 0.44
F3 P13726 1/20 0.44
NR4A2 P43354 1/20 0.44
FADS1 O60427 3/20 0.44
MAPT P10636 2/20 0.44
ALDH1A1 P00352 1/20 0.44
THRB P10828 1/20 0.44
HTT P42858 1/20 0.44
GAA P10253 1/20 0.43
GRM4 Q14833 1/20 0.43
EGFR P00533 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12129007 0.84 SYK (0.55) AHRCMA1ESR1SYKEGFR
SCHEMBL2052877 0.83 ALDH1A1 (0.55) AHRCMA1ESR1SYKMAPT
SCHEMBL12129516 0.78 SYK (0.50) AHRCMA1ESR1SYKF7
SCHEMBL21257479 0.77 KIF11 (0.49) ESR1SYKHTTGRM4EGFR
SCHEMBL1686631 0.76 FADS1 (0.59) FADS1MAPTALDH1A1HTTGAA
SCHEMBL30302564 0.76 AHR (0.56) AHRCMA1ESR1PYGLSYK
SCHEMBL22803637 0.76 AHR (0.56) AHRCMA1ESR1PYGLSYK
SCHEMBL415078 0.75 HTR3E (0.51) TTBK1TTBK2GRM5FADS1MAPT
SCHEMBL12521749 0.75 BTK (0.43) ESR1SYKMAPTEGFR
SCHEMBL5664020 0.75 AHR (0.63) AHRCMA1F7LTA4HF3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1974212-A1 COMPOUNDS USEFUL IN CFTR ASSAYS AND METHODS THEREWITH Vertex Pharmaceuticals Incorporated (US) 2008-10-01 EP disclosed
WO-2007075946-A1 COMPOUNDS USEFUL IN CFTR ASSAYS AND METHODS THEREWITH VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-07-05 WO disclosed